Mouse Encephalomydi~is Virus.--Mouse brain suspensions of the FA and GDVII strains, and spinal cord suspension of the TO strain were kindly supplied by Dr. Karl Habel.
An//sera.--Antiserum for polyoma virus was prepared by intraperitoneal inoculation of weanling Swiss mice with 1:10 dilution of infected tissue culture fluid, using two 0.2 ml. injections 2 weeks apart. The mice were bled by decapitation 10 days after the second inoculation.
For hemaggintination-inkibition tests, myxovirus antisera included rooster serum for various influenza A viruses (Swine, PR8, FM1, FLW-l-52, FW-1-50, Hawaii 303, and Jap/ 305/57), influenza B viruses (1-B-l, Lee, and Va-301-55), and influenza C (1233); chicken and guinea pig serum for NDV; guinea pig serum for Sendal, CA, and mumps; and rabbit serum for HA types I and II. Myxovirus antisera used in CF tests were prepared in guinea pigs, using the same virus strains employed as antigens.
Rooster antiserum for encephalomyocarditis (EMC) virus was kindly supplied by Dr. Kenneth Takemoto. Red Cdl Suspens~ns.--Whole blood of various species was collected in Alsever's solution; the red cells were washed in 3 changes of pH 7.2 phosphate buffered saline and stored at 4°C. either as packed cells or as 1.0 per cent suspension in buffered saline. Guinea pig cells were used as routine for hemagglutination and hemaggiutinationoinkibition tests, and for ceil receptor modification studies.
Receptor-Deslroying Enzyme (RDE)
.
Hemagglutination and Heraagglutination-Inhibi~on (HI)
Te~t~.~For hemagglutination tests, 0.2 ml. of 0.4 per cent guinea pig red cells was added to 0.2 ml. of virus dilution. The tubes were shaken and the cells allowed to settle at 4°C. Readings were made in the cold by the pattern method. Titers were expressed as the highest dilution producing a partial pattern (approximately 50 per cent agglutination).
HI tests employed 0.2 ml. serum dilution and 0.2 ml. of virus diluted to contain 8 to 16 hemagglutinating units. After incubation of the mixtures for 30 minutes at room temperature, 0.1 nil. of 1.0 per cent guinea pig red cells was added, and the tubes were incubated at 4°C. and read as above. Titers were expressed as the highest initial serum dilution giving a distinct button.
Sera were heated as routine at 56°C. for 30 minutes before testing. RDE treatment of serum consisted of ~i~ng equal volumes of undiluted unheated serum and undiluted RDE, or 1 volume of 1:10 serum dilution and 1/10 volume undiluted RDE, incubating for 18 hours at 37°C., and heating at 56°C. for 30 minutes.
All dilutions were made in phosphate buffered saline, pH 7.2.
Treatment of Red Cells with RDE.---0.2 ml. samples of 0.4 per cent guinea pig red cells were treated with an equal volume of serial twofold dilutions of RDE in calcium acetate saline (6) . After incubation at room temperature for 90 minutes, the superuatant fluid was removed and replaced with 8 units of hemagglutinin contained in 0.4 ml. The erythrocytes were then resuspended and allowed to sediment at 4°C.
Preparation of Virus-Treated
Red Ce//s.--Gninea pig red cells were added in a final concentration of 0.5 per cent to undiluted allantoic fluid preparations of influenza A and B viruses, and to undiluted polyoma virus tissue culture fluid, and the suspensions incubated in a 37°C. water bath for 18 hours. Since polyoma-treated red cells usually agglutinated spontaneously even after thorough washing in saline, they were washed once with a 1:800 dilution of~polyoma mouse antiserum, containing 8 HI units, inan attempt to stabilize the suspensions. In certain experiments, influenza A and B virus-treated red cells were washed initially in polyoma antiserum or homologous immune serum. The cells were then washed 3 times in phosphate buffered saline and resuspended to a concentration of 0.4 per cent.
Flectrophore~is.--Measurement of electrophoretic mobility was carried out on the following guinea pig red ceil preparations: (a) untreated cells; (b) cells exposed to control mouse embryo tissue culture fluid; (c) cells exposed to polyoma virus-infected tissue culture fluid having a hemagglutination titer of 1:2550 per 0.2 nil.; and (d) ceils exposed to RDE. Polyoma virus and control fluid treatment consisted of m~Ying 0.25 ml. packed red cells and 7.5 ml. fluid, holding at 4°C. for 1 hour, followed by incubation at 37°C. for 18 hours. For RDE treatment, 0.25 ml. packed cells was added to 7.5 ml. of RDE dilution consisting of 2 parts RDE to 1 part calcium acetate saline, and the mixture incubated at 37°C. for 2 hours. The ceils were washed, thoroughly and resuspended to 1.0 per cent in phosphate buffered saline. Virustreated and 1 aliquot of control fluid-treated cells were washed once in polyoma virus mouse antiserum, diluted 1 : 800. Electrophoresis studies were carried out in a microelectrophoresis apparatus designed by Dr. John W. Hornibrook and used through his courtesy; the internal measurements of the electrophoresis chamber were 12 x 36 x 0.6 mm. The chamber was coated with 1.0 per cent gelatin in distilled water before testing each sample. The time in seconds for an erythrocyte to travel an arbitrary distance, as measured by an ocular micrometer, was determined for each lot of treated cells. Four to 7 readings were made for each group of control cells, and at least 8 determinations for virus-and RDE-treated cells.
O~omucin Inhibitor.--The method of ovomucin preparation was modified from that described by Gottschalk and Lind (7) . Egg white was diluted in approximately 3 volumes of distilled water and the resulting precipitate washed 3 times in 0.5 per cent NaC1 and resuspended in 2 volumes 10 per cent NaC1. The mixture was held overnight at 4°C., centrifuged, and the sediment dispersed in 20 volumes distilled water. The precipitate was washed 3 times and suspended in an equal volume of distilled water; 10 per cent NaC1 was added to a final salt concentration of 0.5 per cent and the mixture homogenized in a Waring blendor for 30 minutes. The supernatant fluid obtained after centrifugation at 2000 R.P.M. for 10 minutes was dialyzed for 50 hours against 2 changes of 1.8 per cent NaCI, and for 35 hours against 3 changes of 1.0 per cent NaC1, and stored at 4°C.
Treatment of ovomucin with virus consisted of adding 1 volume of ovomucin to 2 volumes of undiluted infected allantoic fluid or tissue culture fluid, and incubating at 37°C. for 18 hours. To inactivate the hemagglutinin of the treating virus, ovomucin-myxovirus and ovomucin-potyoma virus mixtures were heated for 30 minutes at 65 ° and 70°C., respectively. Control ovomucin preparations consisted of 1:3 dilutions of ovomucin in saline and in control mouse embryo tissue culture fluid, incubated at 37°C. for 18 hours, and heated at 70°C. for 30 minutes.
To determine residual inhibitor in virus-treated ovomucin, serial 2-fold dilutions of the treated ovomucin samples were prepared and 0.2 ml. of test virus diluted to give a final concentration of 3 to 4 units of hemagglutinin was added to 0.2 ml. of each ovomucin dilution. After 2 hours at 4°C., 0.1 ml. of 1.0 per cent guinea pig red cells was added to each tube; the tubes were placed at 4°C. and read at intervals until complete settling occurred. Controls consisted of titrations of each test virus and determination of the inhibitor titer of salinetreated and control fluid-treated ovomueln against each test virus. Receptor Modification by Virus.--In view of the possible s~milarity of red cell receptors for polyoma virus and members of the myxovirus group as indicated by the action of RDE, it was of interest to test for enzymatic activity of polyoma virus on its cell receptors, and for reciprocal receptor destruction by polyoma and myxoviruses.
RESULTS

Hemagglutlnation of Various Species Erythrocytes.--Tissue
Polyoma virus hemagglutinin readily adsorbed to guinea pig red cells at 4°C., and eluted at 37°C. with varying efficiency. Supematant fluids from mixtures of guinea pig red cells and polyoma virus-infected tissue culture fluid, held at 4°C. for 1 hour, were reduced in hemagglutination titer to 1:10 or less, from a starting titer of 1:2560 or greater. When the cells were resuspended in tissue culture maintenance medium and held at 37°C. for 30 minutes to 2~,~ hours, 50 to 100 per cent of the hemagglutinin was recovered in the fluid phase. However, cells thus exposed remained completely agglutinable on subsequent treatment with fresh virus. The results of titrations of polyoma virus using red cells treated at 37°C. for 18 hours with polyoma virus and influenza virus types A and B are given in Table I . The procedure described in Materials and Methods was followed, with the exception that in test 1, the mixtures of cells plus treating virus were held at 4°C. for 1~,~ hours before incubation at 37°C. Pretreatment of red cells with influenza A and B viruses markedly reduced their agglutinability by polyoma virus. Receptor destruction was prevented by pre~incubation of the treating viruses with homologous immune serum, indicating that receptor modification was a result of viral enzymatic activity, and was not due to some enzyme present in the aUantoic fluid. Cells exposed to polyoma virus showed no detectable exhaustion of receptors for any of the viruses tested. One preparation of polyoma-treated cells (test 1) appeared to be somewhat more sensitive to agglutination than were control cells.
The results of electrophoresis experiments are given in Table II . No difference in mobility of polyoma virus-treated red cells, as compared to untreated or control fluid-treated cells, was detected by a procedure which indicated an approximate 4-fold decrease in mobility of RDE-treated cells.
Serum Inhibitors.--In standard HI tests employing 8 to 16 units of hemagglutinin, RDE-sensitive inhibitor of polyoma virus hemagglutination was found in low titer (1:40) in occasional sera from uninoculated mice or from those receiving saline or control tissue culture fluids. In tests in which mouse sera were screened at dilutions of 1:100 and 1:200, RDE-sensitive inhibitor has been encountered rarely. Thus, of 478 sera from uninoculated mice of a variety of inbred and non-inbred strains in infection-free colonies (8), only 2 demon- strated RDE-sensitive inhibitor, both in titers of 1:100. Among 791 Swiss mice receiving control inoculations, one was found to have RDE-sensitive inhibitor, titering 1:200. As shown in Table III , the titer of non-specific serum inhibitor was inversely proportional to the test dose of hemagglutinin. In contrast, only a 4-to 8-fold decrease in inhibitor titer of polyoma-immune mouse serum, either heat-or RDE-treated, was detected with a 64-fold increase in hemagglutinin. RDE treatment of polyoma-immune mouse, hamster, or rabbit serum had no significant effect on HI titers as determined in the standard test. RDE-sensitive inhibitor was found at a dilution of 1:160 in 2 rabbits receiving control tissue culture fluid inoculations. No inhibitor was detected in pooled chicken, calf, or sheep serum, in tests of 1: 20 dilution of unheated serum against 8 to 16 units of virus.
Because of the generally low inhibitor titers, no attempt was made to carry out comparative tests for reciprocal destruction of serum inhibitors by polyoma virus and members of the myxovirus group.
Ovomudn Inkibitor.--An ovomucin preparation with inhibitory activity for myxovirus hemagglutination was found to contain high titer inhibitor for polyoma virus hemagglutinin, permitting cross-tests of inhibitor destruction. The results of a representative cross-test are given in Table IV ; these findings were confirmed in several additional tests. Ovomucin inhibitor titers for polyoma virus were markedly reduced by pretreatment of the ovomucin with influenza A virus and significant reduction was noted with influenza B and CA viruses. No reduction in ovomucin inhibitor titer for any of the viruses tested was detected after treatment of ovomucin with polyoma virus. The test presented in the table appears to be somewhat insensitive for detecting weak enzymatic activity, since no destruction of mumps or Sendai virus inhibitor by the homologous viruses was obtained. However, in an additional test using the same reagents an 8-fold reduction in Sendal inhibitor and a 2-fold reduction, of borderline significance, in mumps inhibitor were detected. In this test polyoma virus showed no evidence of enzymatic activity.
Serologic Teas.--No inhibition of polyoma virus hemagglutination occurred in tests with antisera prepared against representative strains of types A, B, and C influenza viruses, or against Sendal, CA, mumps, NDV, and types I and II HA viruses, in tests performed with 8 hemagglutinating units of polyoma virus and serum dilutions representing at least 8 HI units of homologous antibody.
CF tests using 2 units of polyoma antigen and 8 units of antiserum for the various myxoviruses were completely negative. In addition, no reaction was obtained with 8 units of polyoma mouse antiserum and 4 units of soluble myxovirus CF antigens.
Relation to Other Hemagglutinating Viruses Found in Rod~ts.--Since the hemagglutination properties of certain other viruses found in rodents have attributes in common with polyoma virus it was of interest to confirm the distinctness of polyoma virus from these agents.
Encephalomyocarditis (EMC) virus agglutinates sheep red cells in the cold, and the hemagglutinin can be eluted on warming, but with no loss in agglutinability of the cells (9) . Also, it has been reported that treatment with RDE renders red ceils inagglutinable (10) and prevents adsorption and multiplication of the virus in HeLa cell cultures (11) . Rooster antiserum against EMC virus, having an homologous neutralization titer of 1:3125, was treated with RDE; this serum in a dilution of 1:40 was negative in HI tests against 8 units of polyoma hemagglutinin. The GDVII strain of mouse encephalomyelitis virus agglutinates human red cells in the cold, and elutes on warming, the cells remaining agglutinable (12) . Mouse protection tests were performed in which polyoma-immune mice were challenged with the TO, FA, and GDVII strains. Weanling Swiss mice were immunized with high fiter polyoma virus-infected tissue culture fluid by giving 2 intraperitoneal inoculations of undiluted fluid 1 week apart. Twenty days after the second injection equal numbers of polyoma-immunized and uninoculated control mice were challenged with each strain of virus as a 10 per cent brain or cord suspension; challenge with FA and GDVII strains consisted of intracerebral inoculation of 0.04 ml. volumes; TO-challenged mice received 0.02 ml. intraspinally. Results are given in Table V ; all positive mice succumbed with typical paralytic symptoms.
Lung extracts from mice or hamsters infected with pneumonia virus of mice (PVM) contain an agglutinin for mouse and hamster red cells (13, 14) . In the infected lung, the virus is firmly combined with a tissue component which prevents hemagglutination (15) . Dissociation of hemagglutinin from inhibitor occurs on heating to 70°C., the property of hemagglutination being much more stable than infectivity; such heating is also required to release the virus from agglutinated red ceils (14) . Reagents were not available for serologic comparisons of polyoma virus and PVM. However, polyoma virus hemagglutinin and infectivity are resistant to heating at 60°C. for 30 minutes but are destroyed or very much reduced after 30 minutes at 70°C. (16) ; there are also marked differences in pathogenicity and in the species of erythrocytes susceptible to agglutination. 
DISCUSSION
The following considerations suggest that the red cell receptors involved in polyoma virus hemagglutination are very similar to the mucoprotein red cell substrates of myxoviruses:--1. Red cells exposed to the action of RDE or to the enzymatic activity of influenza viruses types A and B were inagglutinable by polyoma virus.
2. RDE-sensitive inhibitor active against polyoma virus hemagglutiuation was found in certain normal sera.
3. An ovomucin preparation inhibited polyoma virus hemagglutination, and this inhibitor was susceptible to destructive activity by certain members of the myxovirus group.
However, no enzymatic activity for polyoma virus was demonstrated, since polyoma virus produced no detectable modification in red cell agglutinabllity or ovomucin inhibition of polyoma or myxoviruses. Also, no alteration in electrophoretic mobility of polyoma-treated red cells was detected. An apparent inhibitor of hemagglutination, which is sensitive to heat and RDE, has been detected in cell-free saline eluates obtained after treatment of red cells with polyoma virus (17) . It is possible that this inhibitor represents receptor sub-stance and its presence may indicate an otherwise undetectable modification of the red cell surface. Repeated treatment of red cells with fresh virus might result in some detectable receptor modification.
Although polyoma virus and myxoviruses apparently attach to the same erythrocyte receptors, there is adequate evidence that polyoma virus is not a member of the myxovirus group. The temperature instability, ether sensitivity, and 80 to 150 m/~ size range considered characteristic of the myxovirus group are not associated with polyoma virus. Polyoma virus withstands prolonged storage at 4°C. and heating at 60°C. for 30 minutes without decrease in infectivity titer (16) , is ether-resistant (18), and has a particle size of approximately 40 to 60 m# diameter (19) .
RDE-removable red cell receptors have been described for two other viruses otherwise apparently different biologically from members of the myxovirus group, namely, EMC virus and the rat virus (RV) of Kilham (20) . Studies of destruction of cell receptors for these viruses by influenza virus action have not been reported. Both are serologically distinct from polyoma virus.
SUMMARY
Treatment of guinea pig erythrocytes with types A and B influenza viruses rendered them inagglutinable by polyoma virus; also, the inhibitory effect of ovomucin on polyoma virus hemagglutination was destroyed by pretreatment of the ovomucin with various myxoviruses. These results indicate that polyoma virus and myxovirus erythrocyte receptor sites are identical. However, no destruction by polyoma virus of its own or of myxovirus receptors or inhibitors was detected.
No serologic relationship was detected between polyoma virus and members of the myxovirus group; differences in size and stability further indicate their distinctness.
No evidence was found of biologic or serologic relationship of polyoma virus with encephalomyocarditis virus or mouse encephalomyelitis virus. 
